Abstract:Glucagon stands out as a pivotal peptide hormone, instrumental in controlling blood glucose levels and lipid metabolism. While the formation of glucagon amyloid fibrils has been documented, their biological functions remain enigmatic. Recently, we demonstrated experimentally that glucagon amyloid fibrils can act as catalysts in several biological reactions, including esterolysis, lipid hydrolysis, and dephosphorylation. Herein we present a multiscale quantum mechanics/molecular mechanics (QM/MM) simulation of the acylation step in the esterolysis of para-nitrophenyl acetate (p-NPA), catalyzed by native glucagon amyloid fibrils, serving as a model system to elucidate their catalytic function. This step entails a concerted mechanism, involving proton transfer from serine to histidine, followed by the nucleophilic attack of serine oxy anion on the carbonyl carbon of p-NPA. We computed the binding energy and free-energy profiles of this reaction using the PDLD/S-LRA-2000 and the empirical valence bond (EVB) methods. This included simulations if the reaction in an aqueous environment and in the fibril, enabling us to estimate the catalytic effect of the fibril. Our calculations obtained a barrier of 23.4 kcal∙mol–1 for the enzyme-catalyzed reaction, compared to the experimental value of 21.9 kcal∙mol–1 (and a calculated catalytic effect of 3.2 kcal∙mol–1 compared to the observed effect of 4.7 kcal∙mol–1) This close agreement together with the barrier reduction when transitioning from the reference solution reaction to the amyloid fibrils provides supporting evidence to the catalytic role of glucagon amyloid fibrils. Moreover, by employing the PDLD/S-LRA-2000 approach further reinforced exclusively the enzyme's catalytic role. The results presented in this study contribute significantly to our understanding of the catalytic role of glucagon amyloid fibrils, marking, to the best of our knowledge, the first mechanistic investigation of fibrils using QM/MM methods. Therefore, our findings offer fruitful insights for future research on the mechanisms of related amyloid catalysis.

Energy Landscapes and Structural Ensembles of Glucagon-like Peptide-1 Monomers

Polymorphic amyloid nanostructures of hormone peptides involved in glucose homeostasis display reversible amyloid formation

Energy Landscapes of the Monomer and Dimer of the Alzheimer’s Peptide Aβ(1–28)

Molecular Insights into Ago-Allosteric Modulation of the Human Glucagon-Like Peptide-1 Receptor

Stabilities and Structures of Islet Amyloid Polypeptide (IAPP22-28) Oligomers: from Dimer to 16-Mer.

Assessing the Catalytic Role of Native Glucagon Amyloid Fibrils

Study of Insulin Aggregation and Fibril Structure under Different Environmental Conditions

Computational Insight Into Conformational States Of Glucagon-Like Peptide-1 Receptor (Glp-1r) And Its Binding Mode With Glp-1

Structural basis for the therapeutic advantage of dual and triple agonists at the human GIP, GLP-1 or GCG receptors

Heterogeneous and Surface-Catalyzed Amyloid Aggregation Monitored by Spatially Resolved Fluorescence and Single Molecule Microscopy

Novel insights into the dynamics behavior of glucagon-like peptide-1 receptor with its small molecule agonists

Structure and Thermodynamics of Amylin Dimer Studied by Hamiltonian-Temperature Replica Exchange Molecular Dynamics Simulations

Cryo-EM structure of the activated GLP-1 receptor in complex with a G protein

Engineering Supramolecular Nanofiber Depots from a Glucagon-Like Peptide-1 Therapeutic

Investigation of supramolecular structures in various aqueous solutions of an amyloid forming peptide using small-angle X-ray scattering

Early Events in Insulin Fibrillization Studied by Time-Lapse Atomic Force Microscopy

Lability landscape and protease resistance of human insulin amyloid: a new insight into its molecular properties

Deciphering the Molecular Dance: Exploring the Dynamic Interplay Between Mouse Insulin B9-23 Peptides and Their Variants

Energy Landscapes Associated with the Self-Aggregation of an Alanine-Based Oligopeptide (Aaka)(4)

Dynamics of GLP-1R peptide agonist engagement are correlated with kinetics of G protein activation

Structural basis of peptidomimetic agonism revealed by small-molecule GLP-1R agonists Boc5 and WB4-24